Interest Expense in USD of GALECTIN THERAPEUTICS INC from 2017 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
GALECTIN THERAPEUTICS INC quarterly/annual Interest Expense history and change rate from 2017 to Q1 2024.
  • GALECTIN THERAPEUTICS INC Interest Expense for the quarter ending 31 Mar 2024 was $1.05M, a 129% increase year-over-year.
  • GALECTIN THERAPEUTICS INC Interest Expense for the twelve months ending 31 Mar 2024 was $3.38M, a 167% increase year-over-year.
  • GALECTIN THERAPEUTICS INC annual Interest Expense for 2023 was $2.79M, a 170% increase from 2022.
  • GALECTIN THERAPEUTICS INC annual Interest Expense for 2022 was $1.03M, a 111% increase from 2021.
  • GALECTIN THERAPEUTICS INC annual Interest Expense for 2021 was $489K, a 462% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

GALECTIN THERAPEUTICS INC Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $3.38M $1.05M +$592K +129% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024
Q4 2023 $2.79M $847K +$539K +175% 01 Oct 2023 31 Dec 2023 10-K 29 Mar 2024
Q3 2023 $2.25M $835K +$566K +210% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2023
Q2 2023 $1.69M $650K +$421K +184% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 $1.27M $460K +$233K +103% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q4 2022 $1.03M $308K +$37K +13.7% 01 Oct 2022 31 Dec 2022 10-K 29 Mar 2024
Q3 2022 $996K $269K +$158K +142% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023
Q2 2022 $838K $229K +$144K +169% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 $694K $227K +$205K +932% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 $489K $271K +$249K +1132% 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023
Q3 2021 $240K $111K +$89K +405% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 $151K $85K +$64K +305% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022
Q1 2021 $87K $22K $0 0% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q4 2020 $87K $22K $0 0% 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2022
Q3 2020 $87K $22K $0 0% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021
Q2 2020 $87K $21K $0 0% 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021
Q1 2020 $87K $22K $0 0% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021
Q4 2019 $87K $22K -$58K -72.5% 01 Oct 2019 31 Dec 2019 10-K 31 Mar 2021
Q3 2019 $145K $22K -$65K -74.7% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020
Q2 2019 $210K $21K -$64K -75.3% 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020
Q1 2019 $274K $22K -$62K -73.8% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020
Q4 2018 $336K $80K 01 Oct 2018 31 Dec 2018 10-K 16 Mar 2020
Q3 2018 $87K 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019
Q2 2018 $85K 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019
Q1 2018 $84K 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019

GALECTIN THERAPEUTICS INC Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.79M +$1.76M +170% 01 Jan 2023 31 Dec 2023 10-K 29 Mar 2024
2022 $1.03M +$544K +111% 01 Jan 2022 31 Dec 2022 10-K 29 Mar 2024
2021 $489K +$402K +462% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023
2020 $87K $0 0% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022
2019 $87K -$249K -74.1% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2021
2018 $336K +$324K +2700% 01 Jan 2018 31 Dec 2018 10-K 16 Mar 2020
2017 $12K 01 Jan 2017 31 Dec 2017 10-K 06 Mar 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.